---
source_pdf_path: Resources/fendo-17-1919404.pdf
slug: sun-2026-digital-twins-diabetes
ledger_status: TRIAGED
---

# sun-2026-digital-twins-diabetes

## Bibliographic
- Title: Cross-fusion of digital twins and artificial intelligence in diabetes: from mechanistic elucidation to full-cycle precision management
- First author / authors (first 3 + et al.): Sun Y, Yang R, Xin Q, Luo X, Zhou Y, et al.
- Year: 2026
- Venue: Frontiers in Endocrinology 17:1919404
- DOI: 10.3389/fendo.2026.1919404

## One-line claim
Digital twins in diabetes achieve clinical utility by continuous personalized calibration against incoming data, with Bayesian and residual-learning methods enabling closed-loop feedback between model and patient, exemplified by glucose prediction and insulin dosing systems.

## T6 targeted questions
- **Q-A geometry perturbation**: Not applicable (non-cardiovascular domain). However, paper emphasizes that personalized model calibration may fail when patient presents with "specific genotype or rare complications" leading to "insufficient parameter identifiability or difficulties in fitting."
- **Q-B decision flip**: Not reported (no threshold-based clinical decision analog to FFR 0.80).
- **Q-C BC tuning**: Directly relevant: "digital twins leverage real-world clinical data for continuous calibration of model parameters. The optimized predictive outputs are subsequently relayed back to clinicians and patients, whose post-intervention data is funneled back into the model, thereby establishing an iterative clinical-model-clinical feedback loop." Paper explicitly describes re-calibration after patient intervention; parameters adapt via "residual learning or parameter adaptation methods."
- **Q-D fidelity / quantity**: Reduced-order (compartment ODE models). No WSS/OSI; focus on glucose dynamics and insulin kinetics.
- **Q-E data**: Multiple cohorts cited: ADVICE4U trial (T1DM), cross-sectional metabolomic/anthropometric cohort (elderly T2DM), small real-world observation cohort (HDT framework). N ranges from small (real-world) to population-level (metabolomic profiling).
- **Q-F meshing**: Not applicable.

## Novelty bearing on T6
- bucket: SUPPORT
- one-line reason: Demonstrates how boundary-condition-like parameters (insulin dosing, calibration coefficients) are tuned iteratively after patient-specific data arrives; shows closed-loop feedback model re-personalizing after measurement.
- verdict: LIGHT
- revisit-if: Specific reporting on how model re-tuning masks or compensates for misspecified physiological structure emerges.
